Who are the key players in the Orencia (Abatacept) Market Report 2026 market?

Major companies operating in the Orencia (Abatacept) Market Report 2026 market are Major companies operating in the orencia (abatacept) market are Bristol-Myers Squibb (BMS) Read More

What are the major opportunities in the Orencia (Abatacept) market? What are the strategies for the Orencia (Abatacept) market?

For detailed insights on the major opportunities and strategies in the Orencia (Abatacept) market, Read More

How does the Orencia (Abatacept) market relate to the overall economy and other similar markets?

For detailed insights on Orencia (Abatacept)'s relation to the overall economy and other similar markets, Read More

What are the latest mergers and acquisitions in the Orencia (Abatacept) industry?

For detailed insights on the mergers and acquisitions in the Orencia (Abatacept) industry, Read More

What are the key dynamics influencing the Orencia (Abatacept) market growth? SWOT analysis of the Orencia (Abatacept) market.

For detailed insights on the key dynamics influencing the Orencia (Abatacept) market growth and SWOT analysis of the Orencia (Abatacept) industry, Read More

Orencia (Abatacept) Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Orencia (Abatacept) Market Report 2026

Name: Orencia (Abatacept) Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Prefilled Syringe, Vial), By Application (Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Psoriatic Arthritis), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Orencia (Abatacept) Market Overview

• The Orencia (Abatacept) market growth in the historic period has been driven by rising rheumatoid arthritis prevalence, limitations of conventional dmards

• Market expansion is supported by growth in autoimmune disease diagnosis, increased pediatric arthritis treatment

• Growth Driver: Rising Prevalence Of Autoimmune Disorders Drives Growth In The Orencia (abatacept)Market

• Market Trend: Advancements In The Orencia (Abatacept) Market With The Focus On Innovative Treatments And Expanding Indications For Juvenile Psoriatic Arthritis

• North America was the largest region in 2025.

What Is Covered Under Orencia (Abatacept) Market?

Orencia (abatacept) is a prescription medication used to treat certain autoimmune diseases. It is classified as a selective T-cell co-stimulation modulator, which suppresses overactive immune responses that cause inflammation and tissue damage.

The main types of orencia (abatacept) are prefilled syringes, and vial. A prefilled syringe of Orencia refers to a single-dose syringe preloaded with the medication Orencia (abatacept), which is used to treat autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, and juvenile idiopathic arthritis. These are used in various applications such as rheumatoid arthritis, juvenile idiopathic arthritis, and psoriatic arthritis and are distributed through various distribution channels such as hospital pharmacies, retail pharmacies, and online pharmacies.

Orencia (Abatacept) Market Global Report 2026 Market Report bar graph

What Is The Orencia (Abatacept) Market Size and Share 2026?

The orencia (abatacept) market size has grown rapidly in recent years. It will grow from $3.05 million in 2025 to $3.41 million in 2026 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to rising rheumatoid arthritis prevalence, limitations of conventional dmards, approval of selective t cell therapies, specialist rheumatology adoption, improved clinical outcomes.

What Is The Orencia (Abatacept) Market Growth Forecast?

The orencia (abatacept) market size is expected to see rapid growth in the next few years. It will grow to $5.27 million in 2030 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to growth in autoimmune disease diagnosis, increased pediatric arthritis treatment, expansion of biologic reimbursement, development of biosimilar competition, rising patient adherence to biologics. Major trends in the forecast period include growing adoption of t cell modulation therapies, expansion of biologic treatments for autoimmune diseases, shift toward targeted immune suppression, increased use in juvenile and adult arthritis, rising preference for long term disease control.

Book your 30 minutes free consultation with our research experts

Global Orencia (Abatacept) Market Segmentation

1) By Type: Prefilled Syringe, Vial

2) By Application: Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Psoriatic Arthritis

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What Are The Drivers Of The Orencia (Abatacept) Market?

The rise in the prevalence of autoimmune disorders is expected to propel the growth of the orencia (abatacept) market going forward. Autoimmune disorders are conditions where the immune system mistakenly attacks the body's own cells, tissues, or organs, causing inflammation and damage, leading to chronic conditions like rheumatoid arthritis or multiple sclerosis, with causes involving a mix of genetic and environmental factors. The rise in the prevalence of autoimmune disorders is due to factors such as genetic predisposition, environmental triggers, and improved awareness and diagnosis, leading to more cases being identified. Orencia (abatacept) helps manage autoimmune diseases by modulating the immune response through selective T-cell costimulation inhibition, thereby reducing inflammation and preventing immune system attacks on healthy tissues. For instance, in February 2024, according to Arthritis Australia, an Australia-based charitable not-for-profit organisation advocating for people with arthritis and musculoskeletal conditions, by 2025, approximately 562,378 Australians are expected to be living with rheumatoid arthritis (RA), accounting for 14% of the total arthritis population. Therefore, the rise in the prevalence of autoimmune disorders is driving growth in the sports orencia (abatacept) industry.

Rising personalized medicine is expected to propel the growth of the Orencia (abatacept) market going forward. Personalized medicine is a medical approach that tailors treatment and healthcare strategies to the individual characteristics of each patient, such as their genetic makeup, environment, and lifestyle, to achieve the most effective and precise outcomes. The rise of personalized medicine is due to advancements in genomic technologies, increased understanding of molecular biology, growing availability of precision diagnostic tools, and the demand for targeted therapies that improve patient outcomes while minimizing side effects. Orencia (abatacept) helps advance personalized medicine by targeting specific immune system pathways involved in autoimmune diseases, allowing for tailored treatment regimens that minimize systemic side effects and optimize therapeutic outcomes based on an individual’s unique immune response and disease characteristics. For instance, in February 2024, according to the Personalised Medicine Coalition, a US-based hospital and health care organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, rising personalized medicine drives the Orencia (abatacept) industry.

Key Players In The Global Orencia (Abatacept) Market

Major companies operating in the orencia (abatacept) market are Bristol-Myers Squibb (BMS)

Global Orencia (Abatacept) Market Trends and Insights

Major companies operating in the autoimmune disease treatment market are focusing on developing advanced biologic therapies, such as abatacept, to enhance treatment efficacy, improve patient outcomes, and address unmet needs in managing rare autoimmune conditions. Abatacept is a biologic therapy used in the treatment of juvenile psoriatic arthritis (JPsA), a rare autoimmune disease affecting children and adolescents, causing joint inflammation and skin lesions. For instance, in October 2023, Bristol Myers Squibb, a US-based pharmaceutical company, announced the approval of Biologics Licensing Application (sBLA) for abatacept (Orencia) for the treatment of juvenile psoriatic arthritis (JPsA) in patients aged 2 to 17 years by the Food and Drug Administration, a US-based government agency. The approval was based on data from controlled studies involving both adults and children. Specifically, it utilized pharmacokinetic data from studies on adults with rheumatoid arthritis and psoriatic arthritis, as well as safety data from clinical trials involving children aged 2 to 17 years with polyarticular JIA.

Need data on a specific region in this market?

Request Regional Data

Regional Insights

North America was the largest region in the orencia (abatacept) market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Orencia (Abatacept) Market?

The orencia market consists of sales of abatacept-based biologic therapies, injectable and intravenous solutions, and immunomodulatory treatments. Values in this market are ‘factory gate’ values, which represent the value of goods sold by the manufacturers or creators of the goods, whether to other entities (such as wholesalers, distributors, and healthcare providers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Orencia (Abatacept) Market Report 2026?

The orencia (abatacept) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the orencia (abatacept) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Orencia (Abatacept) Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$ billion
Revenue Forecast In 2035	$ billion
Growth Rate	CAGR of 11.8% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Application, Distribution Channel
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Bristol-Myers Squibb (BMS)
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Orencia (Abatacept) Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Orencia (Abatacept) Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Orencia (Abatacept) Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Orencia (Abatacept) Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Growing Adoption Of T Cell Modulation Therapies

4.2.2 Expansion Of Biologic Treatments For Autoimmune Diseases

4.2.3 Shift Toward Targeted Immune Suppression

4.2.4 Increased Use In Juvenile And Adult Arthritis

4.2.5 Rising Preference For Long Term Disease Control

5. Orencia (Abatacept) Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Rheumatology Clinics

5.3 Pediatric Specialty Clinics

5.4 Specialty Pharmacies

5.5 Autoimmune Treatment Centers

6. Orencia (Abatacept) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Orencia (Abatacept) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Orencia (Abatacept) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Orencia (Abatacept) Market Size, Comparisons And Growth Rate Analysis

7.3. Global Orencia (Abatacept) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Orencia (Abatacept) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Orencia (Abatacept) Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Orencia (Abatacept) Market Segmentation

9.1. Global Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prefilled Syringe, Vial

9.2. Global Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Psoriatic Arthritis

9.3. Global Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

10. Orencia (Abatacept) Market Regional And Country Analysis

10.1. Global Orencia (Abatacept) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Orencia (Abatacept) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Orencia (Abatacept) Market

11.1. Asia-Pacific Orencia (Abatacept) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Orencia (Abatacept) Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Orencia (Abatacept) Market

12.1. China Orencia (Abatacept) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Orencia (Abatacept) Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Orencia (Abatacept) Market

13.1. India Orencia (Abatacept) Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Orencia (Abatacept) Market

14.1. Japan Orencia (Abatacept) Market Overview

14.2. Japan Orencia (Abatacept) Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Orencia (Abatacept) Market

15.1. Australia Orencia (Abatacept) Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Orencia (Abatacept) Market

16.1. South Korea Orencia (Abatacept) Market Overview

16.2. South Korea Orencia (Abatacept) Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Orencia (Abatacept) Market

17.1. Western Europe Orencia (Abatacept) Market Overview

17.2. Western Europe Orencia (Abatacept) Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Orencia (Abatacept) Market

18.1. UK Orencia (Abatacept) Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Orencia (Abatacept) Market

19.1. Germany Orencia (Abatacept) Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Orencia (Abatacept) Market

20.1. France Orencia (Abatacept) Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Orencia (Abatacept) Market

21.1. Eastern Europe Orencia (Abatacept) Market Overview

21.2. Eastern Europe Orencia (Abatacept) Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Orencia (Abatacept) Market

22.1. North America Orencia (Abatacept) Market Overview

22.2. North America Orencia (Abatacept) Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Orencia (Abatacept) Market

23.1. USA Orencia (Abatacept) Market Overview

23.2. USA Orencia (Abatacept) Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Orencia (Abatacept) Market

24.1. Canada Orencia (Abatacept) Market Overview

24.2. Canada Orencia (Abatacept) Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Orencia (Abatacept) Market

25.1. South America Orencia (Abatacept) Market Overview

25.2. South America Orencia (Abatacept) Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Orencia (Abatacept) Market

26.1. Middle East Orencia (Abatacept) Market Overview

26.2. Middle East Orencia (Abatacept) Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Orencia (Abatacept) Market

27.1. Africa Orencia (Abatacept) Market Overview

27.2. Africa Orencia (Abatacept) Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Orencia (Abatacept) Market Regulatory and Investment Landscape

29. Orencia (Abatacept) Market Competitive Landscape And Company Profiles

29.1. Orencia (Abatacept) Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Orencia (Abatacept) Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Orencia (Abatacept) Market Company Profiles

29.3.1. Bristol-Myers Squibb (BMS) Overview, Products and Services, Strategy and Financial Analysis

30. Global Orencia (Abatacept) Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Orencia (Abatacept) Market

32. Orencia (Abatacept) Market High Potential Countries, Segments and Strategies

32.1 Orencia (Abatacept) Market In 2030 - Countries Offering Most New Opportunities

32.2 Orencia (Abatacept) Market In 2030 - Segments Offering Most New Opportunities

32.3 Orencia (Abatacept) Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Orencia (Abatacept) Market, Overview Of Key Products - Product Examples

Table 2: Global Orencia (Abatacept) Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Orencia (Abatacept) Market, Supply Chain Analysis

Table 4: Global Orencia (Abatacept) Market, Major Raw Material Providers

Table 5: Global Orencia (Abatacept) Market, Major Resource Providers

Table 6: Global Orencia (Abatacept) Market, Major Manufacturers (Suppliers)

Table 7: Global Orencia (Abatacept) Market, Major Distributors And Channel Partners

Table 8: Global Orencia (Abatacept) Market, Key Technologies & Future Trends

Table 9: Global Orencia (Abatacept) Market, Major Trends

Table 10: Global Orencia (Abatacept) Market, Major End Users

Table 11: Global Orencia (Abatacept) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Orencia (Abatacept) Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Orencia (Abatacept) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Orencia (Abatacept) Market - TAM, US$ Billion, 2025

Table 15: Global Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Orencia (Abatacept) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Orencia (Abatacept) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Asia-Pacific, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Asia-Pacific, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: China, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: China, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: India, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: India, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Japan, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: Japan, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Australia, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Australia, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: South Korea, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: South Korea, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: South Korea, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Western Europe, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Western Europe, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Western Europe, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: UK, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: UK, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: UK, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Germany, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Germany, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Germany, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: France, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: France, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: France, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Eastern Europe, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Eastern Europe, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Eastern Europe, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: North America, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: North America, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: North America, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: USA, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: USA, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: USA, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Canada, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Canada, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Canada, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: South America, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: South America, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: South America, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Middle East, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Middle East, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Middle East, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Africa, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Africa, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Africa, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Global Orencia (Abatacept) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 72: Global Orencia (Abatacept) Market - Company Scoring Matrix

Table 73: Bristol-Myers Squibb (BMS) Financial Performance

Table 74: Global Orencia (Abatacept) Market, Competitive Benchmarking (In USD Billions)

Table 75: Global Orencia (Abatacept) Market, Competitive Dashboard

Table 76: Global Orencia (Abatacept) Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 77: Global, Orencia (Abatacept) Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 78: Global, Orencia (Abatacept) Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Table 79: Global, Orencia (Abatacept) Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

Figure 1: Global Orencia (Abatacept) Market, Overview Of Key Products - Product Examples

Figure 2: Global Orencia (Abatacept) Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Orencia (Abatacept) Market, Supply Chain Analysis

Figure 4: Global Orencia (Abatacept) Market, Major Raw Material Providers

Figure 5: Global Orencia (Abatacept) Market, Major Resource Providers

Figure 6: Global Orencia (Abatacept) Market, Major Manufacturers (Suppliers)

Figure 7: Global Orencia (Abatacept) Market, Major Distributors And Channel Partners

Figure 8: Global Orencia (Abatacept) Market, Key Technologies & Future Trends

Figure 9: Global Orencia (Abatacept) Market, Major Trends

Figure 10: Global Orencia (Abatacept) Market, Major End Users

Figure 11: Global Orencia (Abatacept) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Orencia (Abatacept) Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Orencia (Abatacept) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Orencia (Abatacept) Market - TAM, US$ Billion, 2025

Figure 15: Global Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Orencia (Abatacept) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Orencia (Abatacept) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Asia-Pacific, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Asia-Pacific, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: China, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: China, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: India, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: India, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Japan, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: Japan, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Australia, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Australia, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: South Korea, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: South Korea, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: South Korea, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Western Europe, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Western Europe, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Western Europe, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: UK, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: UK, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: UK, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Germany, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Germany, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Germany, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: France, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: France, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: France, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Eastern Europe, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Eastern Europe, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Eastern Europe, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: North America, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: North America, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: North America, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: USA, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: USA, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: USA, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Canada, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Canada, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Canada, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: South America, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: South America, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: South America, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Middle East, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Middle East, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Middle East, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Africa, Orencia (Abatacept) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Africa, Orencia (Abatacept) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Africa, Orencia (Abatacept) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Global Orencia (Abatacept) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 72: Global Orencia (Abatacept) Market - Company Scoring Matrix

Figure 73: Bristol-Myers Squibb (BMS) Financial Performance

Figure 74: Global Orencia (Abatacept) Market, Competitive Benchmarking (In USD Billions)

Figure 75: Global Orencia (Abatacept) Market, Competitive Dashboard

Figure 76: Global Orencia (Abatacept) Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 77: Global, Orencia (Abatacept) Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 78: Global, Orencia (Abatacept) Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Figure 79: Global, Orencia (Abatacept) Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Rheumatology Therapeutics Market Report 2026 - Global Outlook – By Drug Class (Disease Modifying Anti-Rheumatic Drugs, Nonsteroidal Anti-Inflammatory Drugs, Corticosteroids, Uric Acid Drugs, Other Drugs Classes), By Dist...

Arthritis Monoclonal Antibodies Market Report 2026 - Global Outlook – By Drug (Remicade, Humira, Enbrel, Rituxan, Orencia, Actemra, Simponi, Cimzia, Remsima ), By Application (Rheumatoid Arthritis, Osteoarthritis, Psoria...

Psoriatic Arthritis Treatment Market Report 2026 - Global Outlook – By Drug Class (Nonsteroidal Anti-Inflammatory Drugs (NSAIDS), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biologics, Other Drug Classes ), By Route...

Axial Spondyloarthritis (axSpA) Market Report 2026 - Global Outlook – By Type (Ankylosing Spondylitis (AS), Non-Radiographic Axial Spondyloarthritis (nr-axSpA)), By Commercialized Therapies (Anti-Tumor Necrosis Factor Th...

Gouty Arthritis Market Report 2026 - Global Outlook – By Type (Acute Gouty Arthritis, Chronic Gouty Arthritis), By Treatment (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Pain Reliever, Corticosteroids, Xanthine Oxida...

Osteoarthritis Therapeutics Market Report 2026 - Global Outlook – By Drug Type (Viscosupplementation Agents, Nonsteroidal Anti-inflammatory Drugs, Analgesics, Corticosteroids), By Anatomy (Knee Osteoarthritis, Hip Osteoa...

Osteoarthritis Market Report 2026 - Global Outlook – By Treatment (Medication, Surgery, Therapy), By Diagnosis (Imaging, Joint Fluid Analysis), By Route Of Administration (Parenteral Route, Topical Route, Oral Route), By...

Frequently Asked Questions

How big is the Orencia (Abatacept) Market?

The Orencia (Abatacept) market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

What is the Orencia (Abatacept) market growth?

The global Orencia (Abatacept) market is expected to grow at a CAGR of 11.5% from 2026 to 2035 to reach $ billion by 2035.

Who are the key players in Orencia (Abatacept) market?

Some Key Players in the Orencia (Abatacept) market Include, Bristol-Myers Squibb (BMS) .

What is the anticipated growth trend for the Orencia (Abatacept) market?

Major trend in this market includes: Advancements In The Orencia (Abatacept) Market With The Focus On Innovative Treatments And Expanding Indications For Juvenile Psoriatic Arthritis. For further insights on this market. request a sample here

Which region has the most growth potential in the Orencia (Abatacept) market?

North America was the largest region in the orencia (abatacept) market in 2025. The regions covered in the orencia (abatacept) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.